Clinical Trial Update: The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled furosemide added to standard treatment for COPD exacerbation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease
• Chronic Obstructive Pulmonary Disease Exacerbation

Drugs mentioned

• Inhaled furosemide (furosemide)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Chronic Obstructive Pulmonary Disease Exacerbation, COPD Exacerbation | Phase 3 | Status: UNKNOWN